Pengcheng Luo Selected Research

Pengcheng Luo Research Topics

Disease

16	Inflammation (Inflammations) 02/2024 - 08/2011
12	Neoplasms (Cancer) 01/2023 - 06/2009
8	Fibrosis (Cirrhosis) 02/2024 - 06/2010
5	Renal Cell Carcinoma (Grawitz Tumor) 09/2023 - 06/2009
5	Hypertension (High Blood Pressure) 01/2022 - 10/2008
5	Insulin Resistance 11/2018 - 05/2014
4	Urinary Bladder Neoplasms (Bladder Cancer) 04/2023 - 02/2006
4	Hypertrophy 01/2023 - 09/2012
4	Neoplasm Metastasis (Metastasis) 01/2022 - 06/2014
4	COVID-19 01/2021 - 01/2020
4	Obesity 11/2018 - 05/2014
3	Body Weight (Weight, Body) 02/2024 - 03/2009
3	Fatty Liver 12/2023 - 02/2016
3	Type 2 Diabetes Mellitus (MODY) 12/2023 - 08/2011
3	Carcinoma (Carcinomatosis) 01/2022 - 02/2006
2	Diabetic Nephropathies (Diabetic Nephropathy) 02/2024 - 03/2009
2	Abdominal Aortic Aneurysm 02/2024 - 01/2020
2	Reperfusion Injury 12/2023 - 01/2020
2	Ischemia 08/2023 - 12/2022
2	Ureteral Obstruction 01/2023 - 06/2010
2	Hypoxia (Hypoxemia) 12/2022 - 10/2017
2	Atherosclerosis 02/2021 - 11/2020
2	Cardiomegaly (Heart Hypertrophy) 01/2021 - 09/2012
2	Heart Diseases (Heart Disease) 10/2020 - 01/2020
2	Necrosis 01/2020 - 02/2016
2	Hyperglycemia 08/2010 - 03/2009
1	Vascular Diseases (Vascular Disease) 02/2024
1	Glucose Intolerance 12/2023
1	Liver Cirrhosis (Hepatic Cirrhosis) 12/2023
1	Hydronephrosis 12/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 12/2022
1	Wounds and Injuries (Trauma) 05/2022
1	Chronic Renal Insufficiency 01/2022
1	Colonic Neoplasms (Colon Cancer) 12/2021
1	Osteoporosis 02/2021
1	Atherosclerotic Plaque (Atheroma) 02/2021
1	Pulmonary Hypertension 01/2021
1	Heart Failure 01/2021
1	Left Ventricular Dysfunction 01/2021

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 04/2023 - 06/2010
6	Interleukin-6 (Interleukin 6)IBA 02/2021 - 03/2019
5	Blood Glucose (Blood Sugar)IBA 02/2024 - 03/2009
4	Apolipoproteins E (ApoE)IBA 01/2024 - 01/2015
4	LipidsIBA 12/2023 - 09/2014
4	Long Noncoding RNAIBA 09/2023 - 03/2019
4	Biomarkers (Surrogate Marker)IBA 04/2023 - 06/2014
4	bazedoxifeneIBA 02/2021 - 03/2019
3	Glucose (Dextrose)FDA LinkGeneric 12/2023 - 01/2016
3	mindinIBA 12/2022 - 05/2014
3	EnzymesIBA 01/2017 - 06/2010
3	MicroRNAs (MicroRNA)IBA 08/2016 - 01/2015
3	thymidine kinase 1IBA 06/2010 - 02/2006
2	MicroplasticsIBA 12/2023 - 12/2023
2	salicylhydroxamic acid (SHAM)IBA 01/2023 - 01/2023
2	CholesterolIBA 01/2022 - 03/2009
2	Indicators and Reagents (Reagents)IBA 01/2022 - 02/2021
2	ApolipoproteinsIBA 02/2021 - 01/2020
2	Raloxifene Hydrochloride (Evista)FDA Link 01/2021 - 11/2020
2	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2020 - 03/2019
2	Glycoproteins (Glycoprotein)IBA 01/2020 - 03/2019
2	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 01/2017 - 08/2011
2	Epoxide HydrolasesIBA 08/2015 - 08/2010
2	Messenger RNA (mRNA)IBA 05/2015 - 09/2012
2	EicosanoidsIBA 09/2014 - 08/2011
2	20-hydroxy-5,8,11,14-eicosatetraenoic acidIBA 09/2014 - 03/2009
2	SaltsIBA 09/2012 - 10/2008
1	IronIBA 02/2024
1	Caspase 1 (ICE Protease)IBA 02/2024
1	Terazosin (Hytrin)FDA LinkGeneric 02/2024
1	Environmental Pollutants (Pollutants, Environmental)IBA 12/2023
1	GlycogenIBA 12/2023
1	CateninsIBA 12/2023
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 08/2023
1	Netrin-1IBA 08/2023
1	Polycomb-Group ProteinsIBA 04/2023
1	Carrier Proteins (Binding Protein)IBA 01/2023
1	Amyloid (Amyloid Fibrils)IBA 01/2023
1	RNA (Ribonucleic Acid)IBA 01/2023
1	CreatinineIBA 12/2022
1	fibroblast growth factor 21IBA 12/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 05/2022
1	Antineoplastic Agents (Antineoplastics)IBA 12/2021
1	Epidermal Growth Factor (EGF)IBA 12/2021
1	shikoninIBA 12/2021
1	Growth Factor ReceptorsIBA 12/2021
1	DisintegrinsIBA 12/2021
1	MonocrotalineIBA 01/2021
1	S-nitrosocysteineIBA 01/2021
1	Urea (Carbamide)FDA LinkGeneric 01/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021
1	NitrogenIBA 01/2021
1	C-Reactive ProteinIBA 01/2021
1	ProcalcitoninIBA 01/2021
1	ElastinIBA 01/2020
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2020
1	Angiotensin Receptor AntagonistsIBA 01/2020
1	Matrix Metalloproteinases (MMPs)IBA 01/2020

Therapy/Procedure

8	Therapeutics 01/2023 - 02/2006
1	Immunotherapy 01/2023
1	Glycemic Control 01/2020